优越的基于片段的设计,合成和体外抗瘤活性的伊马替尼比类似物
Hongyu Jiang1, Yuankun Wang1, Maokai Jiang1
1School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shan-dong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, China.
Turkish journal of chemistry
|August 2, 2023
概括
研究人员使用基于片段的药物设计设计设计了新型伊马替尼比类似物. 最强效的化合物I2对人类髓性白血病和对伊马替尼布耐药癌细胞表现出优异的抗瘤活性.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 在瘤学瘤学.
背景情况:
- 伊马替尼 (Imatinib) 是一种用于治疗慢性髓性白血病的氨酸激酶抑制剂.
- 对伊马替尼布耐药性的发展需要新的治疗策略.
- 基于碎片的药物设计是识别新药候选者的强大方法.
研究的目的:
- 设计和合成具有潜在抗瘤活性的新型伊马替尼比类似物.
- 评估合成化合物对白血病细胞系的体外抗瘤疗效.
- 通过分子对接来探索强效化合物的结合模式.
主要方法:
- 合成含有3-(2-amino-2-oxoacetyl) -1-H-indole部分的伊马替尼比类似物.
- 在K562和K562R细胞系上使用MTT试验进行体外抗瘤活性评估.
- 分子对接模拟用于预测化合物-蛋白质相互作用.
主要成果:
- 已经成功合成了几种伊马替尼比类似物.
- 化合物I2在体外对K562和K562R细胞表现出显著的抗瘤活性.
- 与伊马替尼布相比,I2化合物显示出增强的功效,IC50值分别为0.8μM和0.7μM.
结论:
- 设计的伊马替尼类型,特别是I2化合物,是新型抗癌疗法的有希望的候选者.
- 化合物I2显示出在慢性髓性白血病中克服意马替尼抗性的潜力.
- 需要对I2的作用机制和体内疗效进行进一步的研究.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


